Holen Sie sich die Stockscreener-App
1.73
48.66%
-1.64
Handel nachbörslich:
1.69
-0.04
-2.31%
Schlusskurs vom Vortag:
$3.37
Offen:
$1.7
24-Stunden-Volumen:
10.90M
Relative Volume:
12.18
Marktkapitalisierung:
$107.72M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-73.79M
KGV:
-0.9402
EPS:
-1.84
Netto-Cashflow:
$-77.44M
1W Leistung:
-60.77%
1M Leistung:
-63.35%
6M Leistung:
+51.75%
1J Leistung:
+13.82%
1-Tages-Spanne:
$1.48
$1.91
1-Wochen-Bereich:
$1.48
$4.58
52-Wochen-Spanne:
$0.8332
$5.55
Pyxis Oncology Inc Stock (PYXS) Company Profile
Firmenname
Pyxis Oncology Inc
Sektor
Branche
Telefon
(617) 221-9059
Adresse
321 HARRISON AVENUE, BOSTON
Vergleichen Sie PYXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
1.73 | 209.83M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Fortgesetzt | Stifel | Buy |
| 2025-09-04 | Eingeleitet | Guggenheim | Buy |
| 2024-11-21 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-11-08 | Eingeleitet | Stephens | Overweight |
| 2024-08-08 | Eingeleitet | Stifel | Buy |
| 2024-05-07 | Fortgesetzt | Jefferies | Buy |
| 2024-02-09 | Eingeleitet | BTIG Research | Buy |
| 2024-01-23 | Eingeleitet | Leerink Partners | Outperform |
| 2023-09-05 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-11-02 | Eingeleitet | BofA Securities | Neutral |
| 2021-11-02 | Eingeleitet | Credit Suisse | Outperform |
| 2021-11-02 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Pyxis Oncology Inc Aktie (PYXS) Neueste Nachrichten
Is Pyxis Oncology Inc. stock positioned well for digital economyMarket Trend Report & AI Enhanced Trade Execution Alerts - Улправда
Pyxis Oncology stock falls as RBC cuts price target on complex trial data - Investing.com Australia
Will Pyxis Oncology Inc. stock benefit from automationWeekly Risk Report & Free Community Supported Trade Ideas - Улправда
Pyxis Oncology Stock (PYXS) Opinions on Phase 1 Cancer Drug Data - Quiver Quantitative
Pyxis plummets following phase 1 data on candidate for head and neck cancer - Seeking Alpha
Stock Traders Buy Large Volume of Pyxis Oncology Put Options (NASDAQ:PYXS) - MarketBeat
Pyxis Oncology sees cash runway into 4Q26 - TipRanks
Pyxis Oncology stock plummets after early-stage cancer drug data - Investing.com
Pyxis Oncology Reports Strong MICVO Data and Financing - TipRanks
Pyxis Oncology, Inc. Announces Positive Preliminary Phase 1 Data for MICVO - TradingView — Track All Markets
Pyxis Oncology reports positive data for head and neck cancer drug - Investing.com India
Pyxis Oncology (PYXS) shows promising MICVO results and extends cash runway - Stock Titan
Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma - Yahoo Finance
How Low Can Pyxis Oncology Stock Really Go? - Trefis
Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Cumberland Pharmaceuticals (NASDAQ:CPIX) versus Pyxis Oncology (NASDAQ:PYXS) Critical Comparison - Defense World
Macro Review: Is Pyxis Oncology Inc stock recession proofNew Guidance & Safe Entry Trade Signal Reports - BỘ NỘI VỤ
Pyxis Oncology’s Promising Study on PYX-201 and Pembrolizumab in Advanced Solid Tumors - MSN
With Pyxis Oncology Stock Sliding, Have You Assessed The Risk? - Trefis
New Highs: Can Pyxis Oncology Inc stock deliver 10 annual returnsWeekly Profit Report & Smart Investment Allocation Tips - moha.gov.vn
Can Pyxis Oncology Stock Recover If Markets Fall? - Trefis
Will Pyxis Oncology Inc. stock reach Wall Street targetsPortfolio Value Report & Risk Controlled Daily Trade Plans - Newser
Pyxis’s Cancer Bet Has Paid Off So Far - Finimize
Pyxis Oncology (PYXS) Stock Analysis Report | Financials & Insights - Benzinga
Its Stock Has Paid Off Big Time For Pyxis Oncology Inc - Setenews
Leerink Partnrs Weighs in on Pyxis Oncology FY2025 Earnings - MarketBeat
Leerink Partnrs Lowers Earnings Estimates for Pyxis Oncology - Defense World
Pyxis Oncology Files $350 Million Mixed Shelf - marketscreener.com
Pyxis Oncology plans $150M at-the-market stock program - Stock Titan
Pyxis Oncology: MICVO Data Could Be The Tipping Point In 2025 - RTTNews
What drives Pyxis Oncology Inc stock priceStock Screening Results & Free Real-Time Trading Signals - earlytimes.in
Stephens Reaffirms Their Buy Rating on Pyxis Oncology (PYXS) - The Globe and Mail
Stephens & Co. Maintains Pyxis Oncology (PYXS) Overweight Recommendation - Nasdaq
Stephens raises Pyxis Oncology stock price target to $8 on MICVO potential - Investing.com Nigeria
Ready to Jump After Recent Trade: Pyxis Oncology Inc (PYXS) - Setenews
Can Pyxis Oncology Inc. stock weather global recessionSell Signal & Weekly Return Optimization Plans - newser.com
Is Pyxis Oncology Inc. stock vulnerable to regulatory risksPortfolio Value Report & Weekly Momentum Picks - newser.com
What makes Pyxis Oncology Inc. stock attractive to growth funds2025 Market Outlook & Growth Focused Investment Plans - newser.com
Signal strength of Pyxis Oncology Inc. stock in tech scanners - newser.com
Tick level data insight on Pyxis Oncology Inc. volatilityJuly 2025 Decliners & Capital Efficient Trade Techniques - newser.com
Is Pyxis Oncology Inc. stock a bargain at current levels2025 Volatility Report & Weekly Consistent Profit Watchlists - newser.com
Applying Elliott Wave Theory to Pyxis Oncology Inc.July 2025 Fed Impact & Expert Approved Momentum Trade Ideas - newser.com
Can trapped investors hope for a rebound in Pyxis Oncology Inc.2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - newser.com
Pyxis Oncology Reports Increased Losses Amid Development Focus - TipRanks
Pyxis Oncology Inc (PYXS) looking to reclaim success with recent performance - Setenews
How to manage a losing position in Pyxis Oncology Inc.July 2025 Spike Watch & Community Consensus Trade Signals - newser.com
Is Pyxis Oncology Inc. stock gaining market shareJobs Report & Verified Chart Pattern Signals - newser.com
Finanzdaten der Pyxis Oncology Inc-Aktie (PYXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):